Endovia Health Sciences (EDVA) Property, Plant & Equipment (Net) Growth (1y) (2014 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Property, Plant & Equipment (Net) Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.06 Bn | 133.21 Bn | 2.84 Bn | 24.71% |
| 2 | Regeneron Pharmaceuticals | 86.96 Bn | 78.97 Bn | 3.93 Bn | 12.77% |
| 3 | Argenx Se | 64.93 Bn | 59.74 Bn | 1.37 Bn | -99.85% |
| 4 | Moderna | 57.22 Bn | 52.08 Bn | 52.00 Mn | -5.07% |
| 5 | Revolution Medicines | 44.59 Bn | 44.59 Bn | - | - |
| 6 | BeOne Medicines | 40.43 Bn | 35.33 Bn | 1.53 Bn | 1.70% |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 10.87% |
| 8 | Royalty Pharma | 28.17 Bn | 27.34 Bn | - | - |
| 9 | Insmed | 27.60 Bn | 26.43 Bn | 358.27 Mn | 19.14% |
| 10 | Endovia Health Sciences | 821,701.01 | 578,999.01 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -93.68% |
| Dec 31, 2025 | -41.80% |
| Sep 30, 2025 | -61.22% |
| Jun 30, 2025 | -52.29% |
| Mar 31, 2025 | -46.32% |
| Dec 31, 2024 | -93.65% |
| Sep 30, 2024 | -37.30% |
| Jun 30, 2024 | -35.34% |
| Mar 31, 2024 | -32.23% |
| Dec 31, 2023 | -28.55% |
| Sep 30, 2023 | -30.76% |
| Jun 30, 2023 | -16.74% |
| Mar 31, 2023 | -14.99% |
| Dec 31, 2022 | -14.07% |
| Sep 30, 2022 | -0.81% |
| Jun 30, 2022 | -15.34% |
| Mar 31, 2022 | -15.40% |
| Dec 31, 2021 | -16.37% |
| Sep 30, 2021 | 848.94% |
| Jun 30, 2021 | 835.61% |